MusclePharm Corporation announced that on July 22, 2022, the company entered into a Separation and Release Agreement (the 'Separation Agreement') with Sabina Rizvi. Pursuant to the Separation Agreement, Ms. Rizvi acknowledged that her status as an employee of the Company will end on July 22, 2022 (the 'Termination Date'). In addition, Ms. Sabina Rizvi tendered her resignation as a director of the Company effective as of the Termination Date.

Ms. Rizvi's resignation was not the result of any disagreement with the Company relating to its operations, policies or practices. On July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer and director of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company.

Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018.

Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.